Endorsed Guidelines Developed by Other Medical Societies
The following guidelines have been endorsed by the ASPS. The ASPS uses the AGREE-II instrument to determine whether the guideline is developed with an evidence-based process and is applicable to plastic surgeons. Endorsement decisions are approved by the ASPS Executive Committee.
American Academy of Neurology
The American Academy of Neurology represents more than 30,000 physicians, researchers and other healthcare professionals who specialize in neurology and neuroscience. AAN's mission is to promote the highest quality patient-centered neurologic care.
- Botulinum Neurotoxin for the Treatment of Blepharospasm, Cervical Dystonia, Adult Spasticity, and Headache (published April 2016)
- AAN Patient Summary: Botulinum Neurotoxin for the Treatment of Blepharospasm, Cervical Dystonia, Adult Spasticity, and Headache (published April 2016)
Approved for endorsement by the ASPS Executive Committee 03/2016
American Academy of Otolaryngology – Head and Neck Surgery
The American Academy of Otolaryngology - Head and Neck Surgery is the world's largest organization representing specialists who treat the ear, nose, throat and related structures of the head and neck. The mission of the AAO-HNS is to provide the best ear, nose and throat care through professional and public education, research and health policy advocacy.
Approved for endorsement by the ASPS Executive Committee 09/2016
Infectious Diseases Society of America
Infectious Diseases Society of America (IDSA) represents physicians, scientists and other health care professionals who specialize in infectious diseases. IDSA clinical practice guidelines are based on sound scientific evidence for diverse diseases, conditions and interventions.
Approved for endorsement by the ASPS Executive Committee 03/2015
National Comprehensive Cancer Network
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) comprise recommendations on the prevention, diagnosis, and management of malignancies across the continuum of care. The guidelines currently apply to more than 97% of patients living with cancer in the United States and incorporate real-time updates in keeping with the rapid advancements in the field of cancer research and management.
The guidelines can be accessed at the NCCN website. Please note, this website requires visitors to set up a free account to access the specific guidelines mentioned below.
-
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) T-cell Lymphomas (Section on BIA-ALCL, p. 17-18, 100-101)
Referenced with permission from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for T-cell Lymphomas V.2.2017. © National Comprehensive Cancer Network, Inc. 2017. All rights reserved. Accessed [February 15, 2017]. To view the most recent and complete version of the guideline, go online to NCCN.org.
NCCN makes no warranties of any kind whatsoever regarding their content, use or application and disclaims any responsibility for their application or use in any way.
Date last reviewed: February 2017
Approved for endorsement by the ASPS Executive Committee 04/2017
-
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Dermatofibrosarcoma Protuberans
Referenced with permission from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Dermatofibrosarcoma Protuberans V.2.2015. © National Comprehensive Cancer Network, Inc. 2015. All rights reserved. Accessed [October 17, 2015]. To view the most recent and complete version of the guideline, go online to NCCN.org.
NCCN makes no warranties of any kind whatsoever regarding their content, use or application and disclaims any responsibility for their application or use in any way.
Date last reviewed: October 2015
-
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Merkel Cell Carcinoma
Referenced with permission from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Merkel Cell Carcinoma V.2.2015. © National Comprehensive Cancer Network, Inc. 2015. All rights reserved. Accessed [October 17, 2015]. To view the most recent and complete version of the guideline, go online to NCCN.org.
NCCN makes no warranties of any kind whatsoever regarding their content, use or application and disclaims any responsibility for their application or use in any way.
Date last reviewed: October 2015
-
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Melanoma
Referenced with permission from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Melanoma V.3.2015. © National Comprehensive Cancer Network, Inc. 2015. All rights reserved. Accessed [October 17, 2015]. To view the most recent and complete version of the guideline, go online to NCCN.org.
NCCN makes no warranties of any kind whatsoever regarding their content, use or application and disclaims any responsibility for their application or use in any way.
Date last reviewed: October 2015
-
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Basal Cell Skin Cancers
Referenced with permission from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Basal Cell Skin Cancers V.1.2015. © National Comprehensive Cancer Network, Inc. 2015. All rights reserved. Accessed [October 17, 2015]. To view the most recent and complete version of the guideline, go online to NCCN.org.
NCCN makes no warranties of any kind whatsoever regarding their content, use or application and disclaims any responsibility for their application or use in any way.
Date last reviewed: October 2015
-
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Squamous Cell Skin Cancers
Referenced with permission from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Squamous Cell Skin Cancers V.1.2015. © National Comprehensive Cancer Network, Inc. 2015. All rights reserved. Accessed [October 17, 2015]. To view the most recent and complete version of the guideline, go online to NCCN.org.
NCCN makes no warranties of any kind whatsoever regarding their content, use or application and disclaims any responsibility for their application or use in any way.
Date last reviewed: October 2015
Approved for endorsement by the ASPS Executive Committee 12/2015
American Academy of Orthopaedic Surgeons
The American Academy of Orthopaedic Surgeons is the preeminent provider of musculoskeletal education to orthopaedic surgeons and others in the world.
AAOS has developed the following Evidence-Based Clinical Practice Guidelines to serve as educational tools based on an assessment of the current scientific and clinical information and accepted approaches to treatment.
Approved for endorsement by the ASPS Executive Committee 05/2016
Wound Healing Society
The Wound Healing Society (WHS) is a non-profit organization composed of clinical and basic scientists and wound care specialists. The following guidelines from 2014-16 have been written and approved by the WHS.
- Wound healing society 2014 update on guidelines for arterial ulcers (published January 2016)
- WHS guidelines update: Diabetic foot ulcer treatment guidelines (published January 2016)
- Wound healing society 2015 update on guidelines for pressure ulcers (published January 2016)
- Wound healing society 2015 update on guidelines for venous ulcers (published January 2016)
Approved for endorsement by the ASPS Executive Committee 03/2016